Article
Organometallics, Vol. 29, No. 21, 2010 5043
was extracted with diethyl ether (3 ꢀ 30 mL). The combined organic
phases were dried over Na2SO4, filtered, and evaporated to dryness.
The residue was recrystallized from methanol to give 5-tert-butyl-
3-(methoxydiphenylmethyl)-2-(methoxymethoxy)benzaldehyde as
a pale yellow powder. Yield: 76%. Anal. Calcd for C27H301O4 (M =
418.52): C, 77.48; H, 7.22. Found: C, 77.42; H, 7.26. H NMR
(25 ꢀC, CDCl3, 500 MHz): δ 10.22 (s, 1H, CHO), 7.04-7.24 (m,
13H, Ph), 4.31 (s, 2H, -OCH2O-), 3.29 (s, 3H, -OCH3), 3.06 (s,
3H, -PhOCH3), 1.33 (s, 9H, CH3) ppm. 13C NMR (25 ꢀC, CDCl3,
125 MHz): δ 192.0, 157.6, 146.5, 143.2, 136.9, 134.0, 130.9, 127.9,
127.0, 124.7, 101.0, 86.0, 77.1, 57.2, 52.1, 34.8, 31.3 ppm.
Preparation of 5-tert-Butyl-2-hydroxy-3-(hydroxydiphenyl-
methyl)benzaldehyde. Degassed HClconc (25 mL) in i-PrOH
(125 mL) at 0 ꢀC was added to a CH2Cl2 (125 mL) solution of
5-tert-butyl-3-(methoxydiphenylmethyl)-2-(methoxymethoxy)-
benzaldehyde (5.00 g, 11.9 mmol). The resulting solution was
warmed to room temperature over the course of 4 h, and the
stirring was continued overnight. Water (50 mL) was then added
to the resulting solution. The organic phases were separated,
and the aqueous layer was extracted with CH2Cl2 (3 ꢀ 30 mL).
The organic phase was dried over Na2SO4, filtered, and evapo-
rated to dryness. The residue was recrystallized from pentane
to give 5-tert-butyl-2-hydroxy-3-(hydroxydiphenylmethyl)ben-
zaldehyde as a pale yellow powder. Yield: 89%. Anal. Calcd for
C24H24O3 (M = 360.45): C, 79.97; H, 6.71. Found: C, 79.73; H,
6.71. 1H NMR (25 ꢀC, CDCl3, 500 MHz): δ 11.77 (s, 1H,
Ph-OH), 9.94 (s, 1H, CHO), 7.52-6.89 (m, 13H, Ph), 5.25 (s,
1H, C-OH), 1.17 (s, 9H, CH3) ppm. 13C NMR (25 ꢀC, CDCl3,
125 MHz): δ 197.3, 157.3, 145.7, 142.4, 135.5, 134.7, 129.3,
128.1, 127.8, 127.6, 120.3, 82.0, 34.3, 31.2 ppm.
Preparation of 5-tert-Butyl-2-hydroxy-3-(methoxydiphenylmethyl)-
benzaldehyde. Degassed HClconc (5 drops) in MeOH (15 mL) at
room temperature was added to a MeOH (10 mL) suspension of
5-tert-butyl-3-(methoxydiphenylmethyl)-2-(methoxymethoxy)ben-
zaldehyde (3.80 g, 9.01 mmol). The mixture was stirred at room
temperature for 50 min. Water (50 mL) was then added. The
MeOH was removed in vacuo, and the aqueous solution was
extracted with CH2Cl2 (3 ꢀ 30 mL). The organic phase was dried
over Na2SO4, filtered, and evaporated to dryness. The residue was
recrystallized from cold methanol to give 5-tert-butyl-2-hydroxy-
3-(methoxydiphenylmethyl)benzaldehyde as a pale yellow powder.
Yield: 60%. Anal. Calcd for C25H26O3 (M = 374.47): C, 80.18; H,
7.00. Found: C, 80.26; H, 7.10. 1HNMR(25ꢀC, CDCl3, 500 MHz):
δ 11.01 (s, 1H, Ph-OH), 9.91 (s, 1H, CHO), 8.06-7.31 (m, 13H,
Ph), 3.04 (s, 3H, OMe), 1.32 (s, 9H, CH3) ppm. 13C NMR (25 ꢀC,
CDCl3, 125 MHz): δ 195.9, 157.3, 142.2, 141.2, 133.6, 131.6, 129.0,
128.7, 127.6, 127.4, 121.0, 86.2, 51.9, 34.4, 31.4 ppm.
Preparation of 2-(Hydroxydiphenylmethyl)-4-tert-butyl-[6-(2,6-
diisopropylphenyl)]salicylaldimine (1). To a MeOH solution (20 mL)
of 5-tert-butyl-2-hydroxy-3-(hydroxydiphenylmethyl)benzaldehyde
(2.2 g, 6.1 mmol) were added formic acid (5 drops) and 2,6-
diisopropylaniline (1.73 mL, 9.15 mmol) at room temperature.
The mixture was stirred for 2 days, during which time a yellow
solid formed. The solid was next collected by filtration, washed
with cold methanol, and dried under vacuum. Yield: 96%.
Yellow crystals of 2-(hydroxydiphenylmethyl)-4-tert-butyl-[6-(2,
6-diisopropylphenyl)]salicylaldimine (1) suitable for X-ray stud-
ies were obtained by layering hexane onto a CH2Cl2 solution.
Anal. Calcd for C36H41NO2 (M = 519.72): C, 83.20; H, 7.95; N,
2.70. Found: C, 83.57; H, 7.91; N, 2.80. 1H NMR (25 ꢀC, CDCl3,
500 MHz): δ 14.22 (s, 1H, Ph-OH), 8.33 (s, 1H, CHN),
7.37-6.75 (m, 13H, Ph), 5.92 (s, 1H, C-OH), 2.97 (sept, 2H,
CHiso, 3JH,H = 6.5 Hz), 1.175 (d, 12H, CH3(iso), 3JH,H =6.5 Hz),
1.16 (s, 9H, CH3(tert)) ppm. 13C NMR (25ꢀC, CDCl3, 125 MHz):
δ 167.1, 157.6, 146.2, 145.2, 140.8, 139.0, 134.2, 131.9, 127.8,
127.7, 127.2, 125.7, 123.3, 117.8, 82.3, 34.0, 31.2, 28.1, 23.7 ppm.
Preparation of 2-(Methoxydiphenylmethyl)-4-tert-butyl-[6-(2,6-
diisopropylphenyl)]salicylaldimine (2). To a methanol solution
(100 mL) of 5-tert-butyl-2-hydroxy-3-(methoxydiphenylmethyl)-
benzaldehyde (2.0 g, 5.4 mmol) were added formic acid (5 drops)
Table 1. Crystal Data and Structure Refinement Details for
1 and 1b
1
1b
formula
fw
C36H41NO2
519.72
C40H52NNiO2P
668.49
cryst syst
space group
T, K
triclinic
P1
170(2)
triclinic
P1
100(2)
˚
a, A
9.6595(2)
11.1247(2)
14.6231(3)
100.354(1)
102.299(1)
95.643(1)
1494.98(5)
2
11.6789(1)
12.5998(2)
14.3988(2)
109.437(1)
106.588(1)
95.916(1)
1868.34(4)
2
˚
b, A
˚
c, A
R, deg
β, deg
γ, deg
3
˚
V, A
Z
Dcalcd, g cm-3
F(000)
1.154
560
1.188
716
cryst size, mm3
0.33 ꢀ 0.11 ꢀ 0.09 0.32 ꢀ 0.27 ꢀ 0.09
μ, mm-1
0.070
18 359
6075
0.595
42 449
10 836
8730
421
R1 = 0.0351
(wR2 = 0.0826)
R1 = 0.0495
(wR2 = 0.0892)
P
no. of rflns collected
no. of unique rflns
no. of rflns obsd (I > 2σ(I)) 3110
no. of params
R indices (I > 2σ(I))a
356
R1 = 0.0490
(wR2 = 0.0995)
R1 = 0.1063
(wR2 = 0.1418)
P
R indices (all data)a
P
P
a R1 = ||Fo| - |Fc||/ |Fo|. wR2 = [ [w(Fo2 - Fc2)2]/ [w(Fo2)2]].
and 2,6-diisopropylaniline (1.33 mL, 7.1 mmol). The mixture was
stirred for 2 h at reflux, and then overnight at room temperature.
The volatiles were next removed in vacuo to yield a yellow oil.
MeOH (10 mL) was added and the solution left in the refrigerator
at -20 ꢀC overnight. A yellow solid was formed. The solid was
collected by filtration, washed with cold methanol, and dried
under vacuum. Yield: 60%. Anal. Calcd for C37H43NO2 (M =
533.74): C, 83.26; H, 8.12; N, 2.62. Found: C, 83.17; H, 8.30; N,
2.73. 1H NMR (25 ꢀC, CDCl3, 500 MHz): δ 13.44 (s, 1H,
Ph-OH), 8.39 (s, 1H, CHN), 8.14-7.37 (m, 13H, Ph), 3.21 (s,
3
1H, -OMe), 3.02 (sept., 2H, CHiso, JH,H = 6.5 Hz), 1.25 (d,
3
12H, CH3iso, JH,H = 6.5 Hz), 1.49 (s, 9H, CH3tert) ppm. 13C
NMR (25 ꢀC, CDCl3, 125 MHz): δ 166.8, 157.0, 146.2, 142.6,
140.9, 138.8, 130.2, 128.9, 128.2, 127.4, 126.9, 125.3, 123.2, 118.4,
85.9, 52.0, 34.3, 31.6, 28.1, 23.6 ppm.
Preparation of 2-(Hydroxydiphenylmethyl)-4-tert-butyl-[6-(2,6-
diisopropylphenyl)]salicylaldiminate Li(THF)þ Salt (1a). Com-
pound 1 (2 g, 3.85 mmol) and LiCH2TMS (0.398 g, 4.23 mmol)
were combined in a reaction flask in the glovebox. Dry THF
(15 mL) was added at -78 ꢀC and the mixture was stirred for
30 min, followed by stirring at room temperature overnight. The
volatiles were next removed in vacuo and the residue was recrys-
tallized from pentane to give 2-(hydroxydiphenylmethyl)-4-tert-
butyl[6-(2,6-diisopropylphenyl)]-salicylaldiminate lithium salt (1a)
as a white powder. Yield, 89%. Anal. Calcd for C40H48LiNO3
(M = 597.76): C, 80.37; H, 8.09; N, 2.34. Found: C, 80.62; H, 7.83;
N, 2.66. 1H NMR (25 ꢀC, C6D6, 500 MHz): δ 8.06 (s, 1H, CHN),
7.18-6.77 (m, 13H, Ph), 5.24 (s, br, 1H, C-OH), 3.41 (m, 4H,
3
THF), 3.02 (sept., 2H, CH(iso), JH,H = 7.0 Hz), 1.35 (m, 4H,
THF), 1.16 (s, 9H, CH3(tert)), 1.04 (d, 6H, CH3(iso), 3JH,H = 7.0
3
Hz), 0.855 (d, 6H, CH3(iso), JH,H = 7.0 Hz) ppm. 13C NMR
(25 ꢀC, C6D6, 125 MHz): δ 169.1, 168.3, 151.1, 147.3, 140.2, 136.7,
132.7, 132.5, 132.3, 127.9, 127.4, 125.2, 124.0, 122.3, 84.9, 68.1
(THF), 34.8, 32.0, 28.5, 26.1 (THF), 25.8 ppm.
Preparation of 2-(Methoxydiphenylmethyl)-4-tert-butyl-[6-(2,6-
diisopropylphenyl)]salicylaldiminate Liþ Salt (2a). Compound 2
(1.63 g, 3.05 mmol) and LiCH2TMS (0.316 g, 3.36 mmol) were
combined in a reaction flask in the glovebox. Dry THF (15 mL)
was added at -78 ꢀC, and the mixture was stirred for 30 min,
followed by stirring at room temperature overnight. The volatiles
were next removed in vacuo, and the residue was recrystallized